Evidence map›Paper›PMID 40700659›Full record

Observational studyJournal of evaluation in clinical practice2025

MIPS Under Scrutiny: Exploring the Association Between Providers With Fraudulent Practices and Quality Metrics Within MACRA's Framework.

Mahmoud Manouchehri Amoli, Peter J Cunningham, Brian Cassel, Nathan W Carroll, Bassam Dahman

Abstract readObservational Study
In one paragraph

Observational study in Journal of evaluation in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmoud Manouchehri AmoliDepartment of Health Policy, School of Public Health, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0002-4112-4240
Peter J CunninghamDepartment of Health Policy, School of Public Health, Virginia Commonwealth University, Richmond, Virginia, USA.
Brian CasselDepartment of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Nathan W CarrollDepartment of Health Administration, College of Health Professionals, Virginia Commonwealth University, Richmond, Virginia, USA.
Bassam DahmanDepartment of Health Policy, School of Public Health, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0001-7209-5369

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

importanceIdentifying how fraudulent practices affect quality performance metrics is crucial for enhancing healthcare delivery and maintaining the integrity of the Medicare system.

objectiveTo examine the association between fraud and abuse perpetrator providers (FAPs) and their performance on quality metrics within the Merit-Based Incentive Payment System (MIPS) under the Medicare Access and CHIP Reauthorization Act (MACRA).

designA retrospective observational study using exact matching and propensity score matching to balance comparison groups.

settingAnalysis of Medicare Quality Payment Program (QPP) data from 2017 to 2021.

participantsA total of 12,364 physician-year observations, including 1300 provider-year level FAPs identified between 2020 and 2023 and 11,064 matched non-FAPs. EXPOSURES: Provider status as fraud and abuse perpetrators based on inclusion in the List of Excluded Individuals and Entities from the Office of Inspector General. MAIN OUTCOMES AND MEASURES: MIPS scores across key categories: Final score, Quality score, Promoting Interoperability (PI) score, Improvement Activities (IA) score, and Cost score.

resultsFAPs scored significantly lower than non-FAPs in Final score, Quality score, PI score, and IA score (all p < 0.05). The negative impact of FAP status was more pronounced among individual practitioners, while FAPs participating in Advanced Alternative Payment Models exhibited higher scores on certain metrics. No significant differences were observed in Cost scores between FAPs and non-FAPs. CONCLUSIONS AND RELEVANCE: Fraudulent practices are associated with lower performance on quality-related metrics under MACRA's MIPS framework, particularly among individual practitioners. While lower quality scores align with expectations for providers committing fraud, the absence of significant differences in Cost scores highlights potential shortcomings in the MIPS scoring system, suggesting that cost metrics may not be sufficiently sensitive to fraudulent practices. These findings underscore the need for continuous refinement of both quality and cost measures to enhance the integrity and effectiveness of healthcare delivery.

Indexed as

FraudMedicareMedicare Access and CHIP Reauthorization Act of 2015Quality Indicators, Health CareReimbursement, IncentiveHumansQuality of Health CareRetrospective StudiesUnited StatesAPMhealthcare fraudMACRAMedicareMIPSQPPquality metrics

Identifiers

PMID40700659
PMCPMC12286593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.